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Abstract 
Introduction: There has been a recent interest in the pursuit of non-operative management 
(NOM) of acute appendicitis in both pediatric and adult populations. One potential harm of 
NOM is overlooking cases of appendiceal cancer, a rare and often aggressive malignancy due to 
the frequency of late stage at diagnosis. Previous studies have reported an increasing incidence 
of appendiceal neoplasms in the population.  
  
Objective: This study aims to evaluate the incidence of primary appendiceal neoplasm among 
patients who presented with signs and symptoms of acute appendicitis at the University of North 
Carolina Memorial Hospital (UNC-MH) from 2011 to 2015. 
 
Methods: This is a retrospective case-control study of patients at UNC-MH who were treated 
with appendectomy for acute appendicitis. We evaluated the incidence of primary appendiceal 
cancer over time in this population and completed multivariate logistic regression analysis to 
determine factors that are associated with appendiceal cancer diagnosis. 
 
Results: Of the adult patients at UNC-MH presenting with clinically suspicious acute 
appendicitis, the incidence of appendiceal neoplasm was 2.8% (6/213) in 2011, 0.9% (2/209) in 
2012, 3.0% (6/199) in 2013, 2.4% (4/170) in 2014, and 2.3% (5/216) in 2015. The incidence of 
appendiceal neoplasm over 5 years was 2.3% (23/1007) in this patient population. When 
considering only patients without appendiceal perforation on pathology, the incidence of 
appendiceal neoplasm over 5 years was 1.9% (16/832). Using a multivariate logistic regression, 
age (OR 1.03), number of days of abdominal pain (OR 1.16), self-reported fever (OR 2.08), 
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appendiceal width (OR 1.95), and appendiceal wall thickness (OR 1.30) are associated with a 
primary appendiceal neoplasm diagnosis in patients that present with clinical signs and 
symptoms of acute appendicitis. 
 
Conclusions: We recommend that an operative approach to acute appendicitis should remain the 
standard of care, as operative management may not only be diagnostic but potentially 
therapeutic. 
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Background 
Acute appendicitis is an incredibly common cause of abdominal pain in pediatric and 
adult patients, with a lifetime risk of 7-8% (1). There has been a recent interest in the pursuit of 
non-operative management (NOM) of acute uncomplicated appendicitis in both pediatric and 
adult populations. One major risk of NOM is overlooking potential cases of appendiceal cancer. 
Prior studies have reported an increasing incidence of appendiceal neoplasms within the 
population (2,3). McCusker et al. utilized Surveillance, Epidemiology, and End Results (SEER) 
data from 1973 and 1998 on primary appendiceal neoplasms (2). They included 1645 cases in 
their analysis and found the incidence of primary appendiceal tumor to be 0.12 cases per 
1,000,000 people per year. Marmor et al. evaluated the incidence of primary appendiceal tumor 
between 2000 and 2009 using the SEER database (3). During this time period, they found an 
increase in the incidence of appendiceal neoplasms from 0.6 per 100,000 people in 2000 to 0.97 
per 100,000 people in 2009. 
Primary appendiceal neoplasms are often categorized into six primary types: carcinoid, 
mucinous, colonic-type adenocarcinoma, goblet cell carcinoid, signet-ring cell adenocarcinomas, 
and the rare mixed adeno-neuroendocrine carcinoma (MANEC) (4,5) (Figure 1). Carcinoid 
tumors are a type of slow-growing neuroendocrine tumor (NET) that usually originate in the GI 
tract or the lungs (5). Mucinous type are swellings or sacs of mucus that form within the 
appendiceal wall. They can be further divided into mucinous adenoma (cystadenoma) and 
mucinous adenocarcinoma (cystadenocarcinoma). Signet-ring cell adenocarcinomas are more 
rare and difficult to treat than other types of adenocarcinomas. Goblet cell carcinomas have 
features of both adenocarcinomas and carcinoid tumors (5). Finally, the rare MANEC consists of 
dual adeno-carcinomatous and neuroendocrine differentiation (6). The histologic subtype is 
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important to identify on pathology as survival times vary for each of these six subtypes of 
primary appendiceal neoplasm (7) (Figure 2).  
Most appendiceal neoplasms are discovered incidentally in patients who have their 
appendix removed for any reason. Of the over 280,000 appendectomies performed in the United 
States each year, appendiceal tumors are discovered in approximately 0.9-1.4% of the 
appendices that undergo pathologic inspection (7). One study in New Zealand evaluated 7,970 
appendix specimens and identified 74 patients (0.9%) with appendiceal tumors (8).  
Approximately 50% of patients who are diagnosed with an appendiceal tumor originally 
present with signs and symptoms of acute appendicitis (8). However, the incidence of patients 
with clinical appendicitis who are eventually diagnosed with primary appendiceal malignancy is 
unknown. Given the recent desire for NOM of acute uncomplicated appendicitis and the 
increasing incidence of primary appendiceal neoplasm in the general population, overlooking 
cases of appendiceal tumors may be a limitation of NOM. Thus, we sought to determine the 
incidence of patients presenting with signs and symptoms of acute appendicitis who underwent 
appendectomy and had histopathological confirmation of primary appendiceal neoplasm.  
 
Methods 
Sample 
A retrospective case-control study was completed by pulling all patients at the University 
of North Carolina-Memorial Hospital (UNC-MH) who underwent appendectomy from January 
1, 2011 to December 31, 2015. Charts were reviewed in Epic electronic medical record (EMR) to 
confirm that the patients had their appendices removed for clinical suspicion of appendicitis and 
not another medical reason (i.e. endometriosis, Meckel’s diverticulum, perforated diverticulitis). 
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Only patients who were 18 years of age or older at the time of appendectomy were included in 
the study. 
Measures 
Data was extracted from the patient’s medical chart at baseline. Demographic 
information collected included patient sex, race, date of admission, age, and past medical history 
(prior MI, congestive heart failure, peripheral vascular disease, cardiovascular disease, dementia, 
COPD, liver disease, diabetes mellitus, chronic kidney disease, and HIV/AIDS). Signs and 
symptoms of appendicitis at admission were also collected, including the following: right lower 
quadrant (RLQ) pain (Y/N), the number of days in pain, emesis (Y/N), nausea (Y/N), self-
reported fever (Y/N), Rovsing’s sign (Y/N/NA), psoas sign (Y/N/NA), highest recorded 
temperature, and highest WBC count. Abdominal imaging modalities (ultrasound, CT, MRI) 
were recorded as well as whether these imaging techniques revealed a diagnosis of appendicitis.  
Next, the operative report was reviewed and the procedure type was extracted 
(laparoscopic appendectomy, open appendectomy, laparoscopic converted to open 
appendectomy, or other). Occurrence of post-operative complications was also extracted, 
specifically the need for a re-operation, post-operative abscess (abdominal or pelvic), need for 
VIR drain placement, UTI, pneumonia, and wound infection. Discharge date and length of stay 
(days) was also recorded. Finally, the pathology report of the appendix was evaluated, 
specifically the length, width, and wall thickness of the appendix, gross perforation of the 
appendix, and the presence of a fecalith. The presence of absence of primary appendiceal 
malignancy was also recorded, including the type of malignancy if applicable. 
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Statistical Analysis  
The data was first evaluated for distributions, outlier values, and missing data. The 
distributions of the study variables of interest were analyzed across patients with and without a 
diagnosis of primary appendiceal malignancy. The Alvarado Score considers a temperature 
greater than 37.3qC or a white blood cell count greater than 10,000/dL to be clinically predictive 
of acute appendicitis (9). Thus, dichotomized variables for highest WBC count and highest 
recorded temperature were created. 
The number of patients who presented to UNC-MH with signs and symptoms of acute 
appendicitis was recorded for each year (2011 through 2015). Patients who were diagnosed with 
primary appendiceal cancer on appendiceal pathology were also isolated for each year. Using 
this information, the incidence of primary appendiceal malignancy among patients with signs 
and symptoms of appendicitis over time at UNC-MH was calculated. 
Next, crude logistic regression analysis using a joint effects model was completed to 
evaluate factors associated with appendiceal malignancy. The variables considered included 
appendiceal malignancy were age, sex, race, days in pain, emesis, nausea, self-reported fever, 
temperature, WBC count, appendiceal perforation, presence of a fecalith, appendix length, 
appendix width, and appendix wall thickness. Variables with a p-value > 0.20 were dropped one 
at a time. The likelihood ratio (LR) test was used to compare the log likelihood of the fully 
adjusted and partially reduced models. Nine variables were able to be removed from the model: 
sex, race, emesis, nausea, temperature, WBC count, appendiceal perforation, presence of a 
fecalith, and appendiceal length. 
Because NOM has been more commonly recommended for patients with uncomplicated 
(non-perforated) appendicitis, a subgroup analysis was completed to specifically evaluate 
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patients who did not have gross perforation on appendiceal pathology. From this subgroup, the 
incidence of primary appendiceal malignancy among patients with uncomplicated acute 
appendicitis was calculated over the 5-year time period.  
All calculations and statistical analysis were performed in Stata Version 15 (StataCorp. 
2017. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC). 
 
Results 
Demographics 
 Charts for 1,647 patients who underwent appendectomy from 2011 to 2015 at UNC-MH 
were reviewed in Epic EMR. The narrowed study cohort included 1,007 patients who underwent 
appendectomy for a primary episode of acute appendicitis. Of these, 984 had no appendiceal 
malignancy on pathology while 23 patients were diagnosed with primary appendiceal 
malignancy. Baseline demographic and clinical characteristics are reported in Table 1. Both sex 
and race were fairly well-distributed across the two groups. In the benign 
 group, 50% were female and 61% were white, while in the malignancy group 44% were female 
and 78% were white. Age was very right-skewed in the benign group (Figure 3). However, 
patients in the malignancy group tended to be older (mean age 51.61 r 20.21 years) than the 
benign group (mean age 38.05 r 16.48 years). 
Given the small size of the malignancy group and amount of missing data, past medical 
history cannot be accurately compared across the two groups. Regarding patient-reported 
symptoms of appendicitis, almost all patients in both groups (99.4% in the benign and 100% in 
the malignancy) reported RLQ pain. Patients in the malignancy group were more likely to report 
more days in abdominal pain before presentation to the hospital (3.36 r 3.19 days in the 
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malignancy group compared to 2.23 r 1.95 days in the benign group). Interestingly, fewer 
patients in the benign group were likely to report a fever at home (20.4%) as compared to the 
malignancy group (30.4%). 
The presence or absence of Rovsing’s sign and psoas sign was not recorded in the 
majority of patients in both cohorts (85.2% of the malignancy and 78.3% of the benign groups 
for Rovsing’s sign and 87.8% of the malignancy and 95.7% of the benign groups for psoas sign). 
Thus, adequate statistical analysis for this variable was unable to be performed. Highest recorded 
temperature for both groups was similar (36.76 r 1.30qC in the benign group v. 36.91 r 1.01qC 
in the malignancy group). The highest recorded WBC count was also similar between the two 
groups (13.55 r 4.35 in the benign group v. 13.24 r 3.56 in the malignancy group). Regarding 
abdominal imaging for acute appendicitis, the majority of patients underwent a CT scan of the 
abdomen/pelvis (93.4% in the benign and 87.0% in the malignancy group). Of those who had CT 
scan, the majority were diagnosed with appendicitis (98.2% in the benign group and 100% in the 
malignancy group). Interestingly, only 14.0% of the patients who underwent abdominal 
ultrasound imaging (8/57) were diagnosed with appendicitis via this modality. 
Operative and post-operative findings are shown in Table 2. The majority of patients in 
both groups underwent laparoscopic appendectomy (92.5% in the benign and 69.6% in the 
malignancy groups). The average length of stay (LOS) was much longer in the malignancy 
group, which was to be expected (7.87 r 15.97 days as compared to 1.90 r 2.56 days in the 
benign group).  
Incidence 
The incidence of primary appendiceal malignancy in adult patients who presented with 
signs and symptoms of acute appendicitis was 2.8% (6/213) in 2011, 0.9% (2/209) in 2012, 3.0% 
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(6/199) in 2013, 2.4% (4/170) in 2014, and 2.3% (5/216) in 2015. The overall incidence of 
primary appendiceal malignancy over 5 years was 2.3% (23/1007).  
Logistic Regression 
The fully-adjusted predictive logistic regression for a pathologic diagnosis of appendiceal 
malignancy adjusted for age, sex, race, days in pain, emesis, nausea, self-reported fever, 
temperature > 37.3qC, WBC > 10,000, appendiceal perforation, presence of a fecalith, appendix 
length, appendix width, and appendix wall thickness (Table 3). Each variable was evaluated for 
significance within the model and those with a p-value > 0.20 were dropped one by one using the 
LR test. The final reduced model adjusted for age, sex, days in pain, self-reported fever, 
appendiceal width, and appendiceal wall thickness.  
A patient’s age and clinical symptoms of abdominal pain and fever were associated with 
an increased risk of primary appendiceal malignancy as reported in Table 3. For each one-year 
increase in age there is a 1.03 increased odds (95% CI: 1.01, 1.06) of being diagnosed with 
primary appendiceal malignancy. For each extra day that has a patient reports abdominal pain 
upon admission to the emergency department, there is a 1.16 increased odds (95% CI: 1.02, 1.32) 
of being diagnosed with primary appendiceal malignancy. Patients who self-reported a fever at 
home had a 2.08 increased odds (95% CI: 0.75, 5.73) of being diagnosed with primary 
appendiceal malignancy. 
The size of the appendix on pathology was also correlated with an increased risk of 
primary appendiceal malignancy (Table 3). For each 1 centimeter (cm) increase in appendiceal 
width on pathology there was a 1.95 increased odds (95% CI: 1.16, 3.26) of being diagnosed 
with primary appendiceal malignancy. Appendiceal wall thickness was also correlated with 
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malignancy. For each 1 millimeter (mm) increase in wall thickness there is a 1.30 increased odds 
(95% CI: 1.00, 1.69) of being diagnosed with primary appendiceal malignancy. 
Subgroup Analysis: Uncomplicated Acute Appendicitis 
 Because NOM has been primarily recommended for adult patients with uncomplicated 
(non-perforated) acute appendicitis, we completed a subgroup analysis including only patients 
without appendiceal perforation on pathology. Of the 832 patients who did not have perforation, 
16 (1.9%) did have primary appendiceal malignancy on pathology while 816 (98.1%) did not. 
Although this is less than the 2.3% incidence of primary appendiceal malignancy amongst all 
patients who present with acute appendicitis, this still represents a significant risk if a NOM 
strategy is pursued.  
 
Discussion 
 This study was conducted to evaluate the incidence of primary appendiceal malignancy 
amongst adult patients who presented with signs and symptoms of acute appendicitis at UNC-
MH from 2011 to 2015. As management of acute appendicitis begins to shift away from 
operative intervention, understanding the potential harms of NOM is critical. A search of the 
literature yielded multiple studies on the incidence of primary appendiceal malignancy in the 
United States, which has increased over the past few decades. However, current estimates of the 
incidence of primary appendiceal malignancy within the United States are not yet available (10).  
We determined the incidence of primary appendiceal malignancy amongst adult patients 
presenting with acute appendicitis to be 2.3% over 5 years. The incidence of patients with 
uncomplicated (non-perforated) acute appendicitis who were diagnosed with primary 
appendiceal malignancy was 1.9% over 5 years. The decision to pursue NOM in these patients 
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may lead to significant harm, as appendiceal cancer is most often diagnosed on surgical 
pathology instead of imaging or clinical presentation. Given the aggressive nature of some 
appendiceal malignancies, the increase of NOM for treatment of acute appendicitis could lead to 
a later stage of diagnosis for appendiceal malignancy and thus increased morbidity and mortality 
of appendiceal neoplasms. 
Upon review of the current literature, there has not been an evaluation of the incidence of 
primary appendiceal malignancy amongst patients who present with signs and symptoms of 
acute appendicitis (as a primary outcome). One RCT evaluating NOM versus open 
appendectomy noted (as a secondary outcome) that 4 patients (4/273 or 1.5%) were diagnosed 
with appendiceal tumors after presenting with appendicitis and subsequently undergoing 
appendectomy (11). However, there was no discussion about how many patients treated with 
NOM were subsequently diagnosed with appendiceal malignancy. Published studies have instead 
evaluated patients who were diagnosed with primary appendiceal malignancy and retrospectively 
determined their symptoms upon initial presentation. Approximately 50% of patients with 
malignancy originally present with an appendicitis-like picture on presentation (8). 
The association of appendiceal diameter and wall thickness with eventual diagnosis of 
primary appendiceal malignancy (Table 3) suggests that we may be able to predict whether a 
patient will be diagnosed with primary appendiceal malignancy based on the size of the 
appendix. If visualized, the appendix can often be measured on ultrasound or CT 
abdomen/pelvis. Knowing the appendiceal diameter and wall thickness could better inform 
surgeons about a patient’s true risk for appendiceal cancer, leading to a more individualized 
discussion about the risks of NOM treatment for acute appendicitis. 
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One limitation of our study is that we only included patients 18 years of age or older. The 
incidence of primary appendiceal malignancy may be lower in the pediatric population. This 
prediction is supported by our logistic regression, which demonstrated a 1.03 increased odds 
(95% CI: 1.01, 1.06) of primary appendiceal malignancy with each one-year increase in age. 
Thus, the use of NOM for pediatric patients with acute appendicitis may not bear the same 
potential risk for appendiceal malignancy as within the adult population. A key strength of our 
study is its relatively large sample size (n=1,007) and inclusion of cases over a 5-year period of 
time. Furthermore, the hospital at which the study was conducted (UNC-MH) is one of the 
largest hospitals in the state and serves patients from all counties and several neighboring states. 
Thus, our cohort is likely a good representation of the overall population of North Carolina. 
Further studies are needed to corroborate these results, especially in healthcare centers across the 
country. 
This study is the first in which the primary outcome was to determine the incidence of 
primary appendiceal malignancy within a cohort of adult patients presenting with signs and 
symptoms of acute appendicitis. Our results demonstrate the incidence of primary appendiceal 
malignancy among patients presenting with signs and symptoms of acute appendicitis is 
approximately 2.3% over 5 years. If a NOM strategy is pursued, there is a risk of delayed 
diagnosis and increased morbidity given that operative management of acute appendicitis is not 
only diagnostic but potentially therapeutic for appendiceal cancers. 
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Figure 1. Types of primary appendiceal neoplasms 
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Figure 2. Disease-specific survival by histologic subtype (7) 
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Figure 3. Age distribution across benign and malignancy groups 
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Table 1. Baseline Demographic and Clinical Characteristics 
Characteristic Benign n = 984 
Malignancy 
n = 23 
Sex 
Female 
Male 
 
493 (50.1%) 
491 (49.9%) 
 
10 (43.5%) 
13 (56.5%) 
Race 
White 
Hispanic 
African-American 
Asian 
American-Indian 
Other 
 
604 (61.4%) 
219 (22.3%) 
91 (9.25%) 
33 (3.4%) 
1 (0.1%) 
29 (3.0%) 
 
18 (78.3%) 
1 (4.4%) 
3 (13.0%) 
1 (4.4%) 
-- 
-- 
Age (years)‡ 38.05 r 16.48 51.61 r 20.21 
Past Medical History 
Prior MI 
Congestive heart failure 
Peripheral vascular disease 
Cardiovascular disease 
Dementia 
COPD 
Liver disease 
Diabetes mellitus 
Chronic kidney disease 
HIV/AIDS 
 
4 (0.4%) 
10 (1.0%) 
2 (0.2%) 
5 (0.5%) 
2 (0.2%) 
9 (0.9%) 
12 (1.2%) 
47 (4.8%) 
17 (1.7%) 
7 (0.7%) 
 
-- 
-- 
-- 
-- 
1 (4.4%) 
-- 
-- 
1 (4.4%) 
-- 
-- 
Symptoms of Appendicitis 
RLQ pain 
Days in pain‡ 
Emesis 
Nausea 
Fever 
 
978 (99.4%) 
2.23 r 1.95 
412 (41.9%) 
737 (75.0%) 
200 (20.4%) 
 
23 (100%) 
3.36 r 3.19 
5 (21.7%) 
12 (52.2%) 
7 (30.4%) 
Signs of Appendicitis 
Rovsing’s sign 
Psoas sign 
Febrile (temp > 37.3qC) 
Highest temperature (qC)‡  
WBC > 10,000  
Highest WBC count‡ 
 
109 (74.7%) 
57 (47.5%) 
208 (21.3%) 
36.76 r 1.30 
753 (78.3%) 
13.55 r 4.35 
 
2 (40.0%) 
1 (100%) 
6 (26.1%) 
36.91 r 1.01 
17 (77.3%) 
13.24 r 3.56 
Imaging 
CT abdomen/pelvis 
MRI 
Ultrasound 
No imaging 
Appendicitis on CT abdomen/pelvis 
Appendicitis on MRI 
Appendicitis on Ultrasound 
 
919 (93.4%) 
23 (2.3%) 
57 (5.8%) 
34 (3.5%) 
901/919 (98.2%) 
22/23 (95.7%) 
8/57 (14.0%) 
 
20 (87.0%) 
2 (8.7%) 
-- 
1 (4.4%) 
20/20 (100%) 
0/2 (0%) 
-- 
‡Includes standard deviation 
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Table 2. Operative and Post-Operative Findings 
Characteristic Benign n = 984 
Malignancy 
n = 23 
Procedure type 
Laparoscopic appendectomy 
Laparoscopic converted to open 
Open appendectomy (Ex-lap) 
Right hemicolectomy 
 
910 (92.5%) 
55 (5.6%) 
19 (1.9%) 
-- 
 
16 (69.6%) 
-- 
4 (17.4%) 
3 (13.0%) 
LOS (days)‡ 1.90 r 2.56 7.87 r 15.97 
Post-Operative Complications 
Re-operation 
Intra-abdominal abscess 
VIR drainage for abscess 
Pneumonia 
Urinary tract infection 
Wound infection 
 
13 (1.3%) 
54 (5.5%) 
45 (4.6%) 
9 (0.9%) 
2 (0.2%) 
17 (1.7%) 
 
2 (8.7%) 
1 (4.4%) 
1 (4.6%) 
1 (4.4%) 
-- 
-- 
Pathology 
Perforation 
Fecalith present 
Appendix length (cm)‡ 
Appendix width (cm)‡ 
Appendix wall thickness (mm)‡ 
 
168 (17.1%) 
110 (11.2%) 
7.12 r 2.05 
0.96 r 0.48 
2.33 r 1.18 
 
7 (30.4%) 
2 (8.7%) 
6.33 r 2.07 
1.43 r 1.23 
3.37 r 1.80 
‡Includes standard deviation  
Abbreviations: Ex-lap=exploratory laparotomy; LOS=length of stay; VIR=Vascular and Interventional 
Radiology; cm=centimeters; mm=millimeters 
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Table 3. Joint Effects Logistic Regression Model for Appendiceal Malignancy 
 Fully adjusted model* Final reduced model** 
 Odds Ratio 95% CI Odds Ratio 95% CI p-value UCL/LCL 
Age 1.04  (1.01, 1.07) 1.03 (1.01, 1.06) 0.010 1.05 
Sex 0.95  (0.32, 2.84) -- -- -- -- 
Race 
White 
Hispanic 
African-American 
Asian 
 
-- 
0.36 
0.83 
2.40 
 
-- 
(0.04, 2.97) 
(0.14, 4.82) 
(0.25, 22.78) 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
 
-- 
-- 
-- 
-- 
Days in pain 1.13 (0.95, 1.35) 1.16 (1.02, 1.32) 0.028 1.29 
Emesis 0.85 (0.23, 3.09) -- -- -- -- 
Nausea 0.83 (0.23, 2.96) -- -- -- -- 
Self-reported fever 2.52 (0.86, 7.40) 2.08 (0.75, 5.73) 0.158 7.64 
Temp > 37.3qC 1.84 (0.59, 5.75) -- -- -- -- 
WBC > 10,000 1.26 (0.32, 4.93) -- -- -- -- 
Perforation 0.58 (0.16, 2.17) -- -- -- -- 
Fecalith 0.95 (0.20, 4.61) -- -- -- -- 
Appendix length (cm) 1.01 (0.76, 1.35) -- -- -- -- 
Appendix width (cm) 1.99 (1.15, 3.46) 1.95 (1.16, 3.26) 0.011 2.81 
Appendix wall 
thickness (mm) 1.28 (0.97, 1.74) 1.30 (1.00, 1.69) 0.052 1.69 
*Fully adjusted model controls for age, sex, race, days in pain, emesis, nausea, self-reported fever, temperature, 
WBC count, appendiceal perforation, presence of a fecalith, appendix length, appendix width, and appendix wall 
thickness 
**Final reduced model controls for age, sex, days in pain, self-reported fever, appendix width, and appendix wall 
thickness  
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Appendix:  
A Limited Systematic Review of Non-Operative Management of Uncomplicated  
Acute Appendicitis in Adults 
Background 
Acute appendicitis is a common cause of abdominal pain in pediatric and adult patients, 
with a lifetime risk of 7-8% (1). Appendicitis has been considered a surgical disease since the 
first appendectomy was performed in 1735 (12). There are currently over 280,000 
appendectomies performed each year in the United States (13). However, there has been a recent 
push towards non-operative management (NOM) of acute appendicitis in both pediatric and adult 
populations (14). Any operation has the risks of bleeding, infection, damage to surrounding 
organs, and rarely death. Improved surgical technology with laparoscopy has lessened these 
risks, but they still exist (15). In pediatric patients specifically, there is concern about the long-
term effects of surgery. Prior abdominal surgery predisposes patients to the creation of 
adhesions, potentially leading to small bowel obstructions in the future (16). The success of 
NOM in pediatric patients has led to the consideration of NOM for adult patients as well (17). 
Unfortunately, NOM is not without its own potential harms. If the antibiotics are not 
effective, the patient could experience appendiceal perforation, leading to a more complicated 
surgery, longer hospital stay, and increased risk for post-operative abscess requiring drainage. 
Another potential harm of NOM is overlooking cases of appendiceal cancer, a rare but often 
aggressive malignancy due to the frequency of late stage at diagnosis (3). Thus, it is important to 
weigh the harms of operating against those of treating solely with antibiotics, including the risk 
of overlooking cases of appendiceal cancer that could have been treated at an early stage. Due to 
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the relatively high prevalence of acute appendicitis, a transition from operative to NOM of acute 
appendicitis will have major implications. 
 
Rationale and Objectives 
In 2011, a Cochrane systematic review assessed NOM of acute appendicitis in both 
pediatric and adult patients (14). NOM of acute appendicitis is more common in children, but 
less is understood about this modality of treatment for acute appendicitis in adults. The aim of 
this systematic review is to provide an update to the 2011 Cochrane systematic review to include 
more recently published studies specifically evaluating NOM for adults. Thus, my key question 
in performing this systematic review is: what are the benefits and harms of non-operative 
management (antibiotic therapy) compared with appendectomy in adult patients with 
uncomplicated acute appendicitis?  
 
Methods 
Inclusion and Exclusion Criteria 
This review focused on studies that evaluated NOM with antibiotic treatment (oral or 
intravenous), as compared with appendectomy (open or laparoscopic) or no comparison. We 
included randomized clinical trials (RCTs) in which antibiotic therapy (any type) was compared 
with appendectomy in adult patients with suspected appendicitis. Prospective cohort studies and 
case control studies were also included to evaluate potential harms of NOM. Retrospective 
studies, case reviews, systematic reviews (including the 2011 Cochrane review), and meta-
analyses were excluded. 
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The population of interest was adults age 18 years or older with suspected uncomplicated, 
meaning non-perforated, acute appendicitis. There were no restrictions on gender. Pediatric 
patients, pregnant women, patients with complicated or perforated appendicitis, and patients with 
an appendiceal “mass” or phlegmon were excluded. There were few limitations on the outcomes 
evaluated. Eligible outcomes included cure within an amount of time specified by the article 
(free of symptoms such as abdominal pain, fever, inflammatory parameters, etc.), decreased 
hospital length of stay, and patient out of pocket costs. Eligible harms included major 
complications (recurrence risk of appendicitis or eventual need for appendectomy) during the 
time of follow-up. 
Because a recent Cochrane review on NOM of appendicitis evaluated studies published 
before June 2011, I limited this review to studies published after this time point (14). There were 
no limits on the duration of the study or the duration of follow-up. There were no limits placed 
on study setting. Both English and non-English studies were included. The full eligibility criteria 
can be found in Table 1. 
Search Methods 
I searched the PubMed and EMBASE databases from inception until April 5, 2018 using 
the following terms: “acute appendicitis” OR “uncomplicated appendicitis” in conjunction with 
“non-operative” or “non-surgical*” OR “antibiotic*.” I also searched ClinicalTrials.gov using 
“acute appendicitis” as the treatment and “antibiotics” as the intervention. Studies published 
before June 2011 were removed manually via the screening process. No filters were used to limit 
the types of studies, population of interest, or language. 
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Data Collection and Analysis 
I imported all articles found from the three electronic searches in PubMed, EMBASE, and 
ClinicalTrials.gov to Covidence for duplicate removal, screening, and full-text evaluation 
(Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. 
Available at www.covidence.org). I personally examined all titles and abstracts that were 
included in the review. Full copies of all potentially relevant studies were obtained for full-text 
review. From the remaining articles, I recorded the title, authors, year of publication, and 
publication language. I then extracted the following information: study design, location of the 
study, patient population, intervention, comparators, method of randomization for RCTs, primary 
and second outcomes collected, and results. I also collected the number of cases of NOM, initial 
NOM failure rate, recurrence rate, and overall NOM failure rate. Data was extracted using a 
single standardized form. 
I utilized the Cochrane’s risk of bias tool to assess randomized controlled trials and a 
version of the Newcastle-Ottawa Scale adapted for observational studies to assess cohort and 
case-control studies for quality (18,19). All studies were included in data extraction regardless of 
risk of bias. I did not complete any summary measures because of heterogeneity in the study 
outcomes assessed, varied definitions of treatment failure, and differences in follow-up length.   
 
Results 
Study Selection 
My electronic searches yielded 1605 results from PubMed, 444 results from EMBASE, 
and 54 results from ClinicalTrials.gov. After removal of duplicates 1818 results remained for 
screening; 153 articles were deemed potentially eligible and the full-text was retrieved for 
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review. The reasons for exclusion of full-text articles are detailed in Figure 1. After further 
evaluation, 10 articles were included in the systematic review: (11,20–28).  
Results of Individual Studies  
Of the ten studies included, eight were prospective cohort studies, one was a 
nonrandomized controlled trial, and one was a randomized, controlled, non-inferiority trial. 
Detailed data extracted from the ten studies included in the systematic review can be found in 
Table 2. None of the studies were set in the United States and one article was written in French 
(23). All of the studies except Park et al. 2011 specified that the patients included were above a 
certain age cut-off. Some of the studies did include patients <18 years old which we would 
technically consider to be children, but the youngest patients included were in the Bashir 2015 
study (> 12 years old).  
The antibiotic treatment of choice varied for each study, but most included a course of 
intravenous (IV) antibiotics with a transition to oral antibiotics after discharge. One study 
combined patients from three prior studies into one paper and evaluated the long-term harms and 
time to appendectomy for NOM (26). Since three different study protocols were used, there was 
not a single NOM antibiotic regimen used for that study. For all included studies, a rate of initial 
NOM treatment failure was either given or able to be calculated based on the data reported. 
Given the heterogeneity of study outcomes, NOM treatment regimens, follow-up time, and 
definitions of treatment failure, a meta-analysis cannot be completed.  
Risk of Bias Assessment 
Almost all of the included studies were determined to have low or moderate risk of bias 
(Table 3, Table 4). Common potential sources of bias included lack of standardization of the 
study NOM protocol (2/9 observational studies), no specified timepoint at which outcome was 
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assessed (3/9 observational studies), and no blinding of the assessors for the RCT (Salminen 
2015). Since patients were not randomized to NOM in the observational studies and are instead 
self-selecting into NOM instead of surgery, they may not be fully representative of the 
population of interest. 
Of the observational studies evaluated, seven were single cohort studies that did not 
include a comparison group (Table 3). The lack of a comparison cohort contributes significantly 
to selection bias and thus risk of bias overall for cohort studies. Since we do not have an 
unexposed cohort in the study, it is difficult to interpret the results of these studies. The primary 
outcome for these studies was recurrence risk of appendicitis, and thus it may be considered 
reasonable to not include patients that undergo appendectomy as they would theoretically not be 
able to experience a recurrence of appendicitis once their appendix is removed. However, there is 
a rare chance of stump appendicitis or recurrence of appendicitis secondary to appendiceal 
duplication as reported in the literature (29). 
Synthesis of Results 
Initial NOM Treatment Failure 
 Detailed results for all ten included studies can be found in Table 5. There was variation 
across studies in the definition of initial treatment failure. For example, some defined NOM 
treatment failure as persistence of symptoms after 24 hours of treatment with antibiotics while 
others were more conservative and waited up until 7 days. Initial NOM treatment failure rate 
varied widely from 1.3% to 22.6% across studies. The Salminen 2015 study was the only study 
in which patients were randomized to antibiotic therapy or appendectomy (11). In observational 
studies, theoretically the less sick patients would be the ones to self-select into NOM instead of 
surgery. Given that this study was completed as an RCT, it is likely the most representative of 
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our population of interest. The overall treatment failure rate observed in the study was 27.3% and 
may be the best estimation of the true NOM failure rate. 
NOM Recurrence Rate 
Each study had a different length of follow-up from 6 months to 8 years, thus the 
recurrence rates also varied widely from 5.2% to 22.7%. Overall, the failure rate for NOM varied 
widely from 14.0% to 31.2%. The two controlled trials that included comparison groups, 
Hansson 2012 and Salminen 2015, reported the highest rates of overall NOM failure (31.2% and 
27.3% at 1 year follow-up respectively) (11,24). 
Long-Term Harms 
The primary outcome for the Lundholm 2017 study was long-term harms of NOM and 
thus this cohort had the longest average follow-up time (maximum of 8 years) (26). They found 
that the cumulative probability for relapse of appendicitis demanding appendectomy was: 0.09, 
0.12, 0.12 and 0.13 at 1-, 2-, 3- and 5-year follow-up, respectively, with a probability of 0.86 ± 
0.013 without appendectomy after 8 years. Since their study had the longest follow-up time, their 
recurrence rate of 13.1% could be considered to be the most conservative estimate of eventual 
NOM treatment failure (26). However, their study is not without potential bias, as it included 
patients from three prior trials (RCT, PBT, and non-RCT). The NOM antibiotic regimen was not 
standardized across these studies, and thus the ability to combine the patients into one cohort is 
questionable. 
Length of Stay 
The Salminen 2015 study found that the average hospital LOS was significantly shorter 
(p<0.001) for the open appendectomy group (median: 3 days, 25th and 75th percentiles, 2 days 
and 3 days) as compared to the antibiotic therapy group (median: 3 days, 25th and 75th 
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percentiles, 3 days and 3 days) (11). Most patients in the United States with acute appendicitis 
undergo laparoscopic appendectomy, which is an even less invasive surgical procedure and 
would like lead to even shorter hospital stays than open appendectomy. 
 
Discussion 
Across all included studies, rates of treatment failure and recurrence rates varied widely, 
most likely due to differences in definitions, study designs, length of follow-up, and other 
factors. The failure rate for NOM in adult patients with acute uncomplicated appendicitis ranged 
from 1.3% to 22.6%, recurrence rate from 5.2% to 22.7%, and an overall failure rate from 14.0% 
to 31.2%. The wide variation in these rates is likely due to the heterogeneity of study designs, 
including differences in patient selection and antibiotic treatment.  
Limitations 
 This body of literature has limitations. In terms of populations, although the scope of this 
review was limited to adults only (>18 years old), most of these studies evaluated adult patients 
in addition to some portion of the pediatric population and did not stratify their results by age. 
Thus, there is a need for more studies evaluating the recurrence rate of appendicitis after NOM in 
adult-only populations. Another limitation is the applicability of these studies to the population 
within the United States. The studies were completed in Iraq, Saudi Arabia, Morroco, Korea, 
Italy, Sweden, Turkey, and Finland. Of these countries, Finland (Salminen 2015) and Sweden 
(Hansson 2012) have the most similar demographic makeup to the United States. However, more 
studies are needed within the U.S. to control for differences within populations.   
 Patients were only randomized to NOM versus surgery in one single study (Salminen 
2015). The study demonstrated a NOM treatment overall failure rate of 27.3%, which was the 
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second highest estimate from this group of studies (Table 5). This suggests that patients in the 
observational studies could be self-selecting into NOM only if their abdominal symptoms are 
less severe. This could lead to an underestimation of the true NOM failure rate as only patients 
with less severe symptoms are willing to undergo NOM. Thus, more randomized controlled trials 
are needed to better understand the true failure rate of NOM. Interestingly, a protocol for an RCT 
being completed at UCLA was found on ClinicalTrials.gov during the full-text review for this 
systematic review (30). The RCT only recently finished enrolling patients, but the results from 
this study are likely to be the most accurate representation of NOM failure within the U.S. (31).  
 Finally, there is also a need for more information on the long-term harms and risk of 
eventual recurrence of acute appendicitis for patients treated with NOM. The majority of studies 
included in this systematic review (9/10 studies) followed patients for two years or less. It is 
possible that patients could have recurrence of appendicitis after this time period. Although long-
term follow-up of patients can be difficult, it is imperative to accurately represent the recurrence 
rate of appendicitis in adult patients treated with NOM as compared to appendectomy. 
Conclusions 
 Overall, this systematic review demonstrated an initial failure rate for NOM in adult 
patients with acute uncomplicated appendicitis from 1.3% to 22.6%, a recurrence rate from 5.2% 
to 22.7%, and an overall failure rate from 14.0% to 31.2%. Although these numbers vary, the 
true failure rate is likely closest to that observed within the Salminen 2015 study (27.3%), as 
patients were randomized to NOM or surgery (11). Results of this review did not find a precise 
NOM failure rate for acute uncomplicated appendicitis in the published literature, but patients 
who are strongly averse to appendectomy for acute uncomplicated appendicitis should be offered 
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NOM with proper education about its benefits and risks, including recurrence and missed cases 
of appendiceal malignancy. 
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Figure 1. PRISMA Diagram 
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Table 1. Systematic Review Inclusion and Exclusion Criteria 
 Inclusion Criteria Exclusion Criteria 
Population 
Adults ages 18 years or older with 
suspected uncomplicated (non-perforated) 
acute appendicitis 
Pediatric patients (less than 18 years old), 
pregnant women, patients with 
complicated (perforated) appendicitis or 
appendiceal “mass” (phlegmon) 
Intervention 
Non-operative management (aka 
conservative therapy/treatment) with 
antibiotics 
Abdominal drain placement, interval 
appendectomy 
Comparisons Appendectomy (open or laparoscopic) or no comparison -- 
Outcomes 
Benefits (cost to the patient, time in the 
hospital) and harms (eventual need for 
appendectomy, recurrence risk for 
appendicitis) 
-- 
Timing Studies published after June 2011 -- 
Setting No limits, both English and non-English studies were included -- 
Study 
Designs 
Randomized clinical trials, prospective 
cohort studies, case control studies 
Retrospective studies, case reviews, 
systematic reviews, meta-analyses 
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Table 2. Study Details for Systematic Review of NOM for Acute Appendicitis 
First 
Author 
and Year 
Study Design Location(s) Language Time Period Patient Population Population (N) Intervention Comparator Outcomes 
Alnaser 
2018 
 
Prospective 
cohort study 
Al-Kindy College of 
Medicine in Baghdad, 
Iraq 
English 
January 2015 
- December 
2016 
Pts > 16yo w hx of pain in 
RLQ for < 72hrs diagnosed 
as the first attack of acute 
appendicitis w Alvarado 
score t 5 
90 NOM 
IV abx (cefotaxime 1g BID + 
metronidazole 500mg/100mL TID) for at 
least 24hrs 
If pain improved, transitioned to oral 
antibiotics (ciprofloxacin 500mg TID + 
metronidazole 500mg TID for 10 days) 
N/A Treatment efficacy 
Bashir 
2015 
Prospective 
cohort study 
King Fahad Hospital in 
Al-Baha, Saudi Arabia 
(KSA) 
English 
August 2011 
- August 
2012 
Pts > 12yo w clinically 
suggestive appendicitis 
305 total  
(176 NOM) 
NPO, IVF, single shot of cefuroxime + 
flagyl in "selected patients" for 1 day Appendectomy Treatment efficacy 
Di 
Saverio 
2014 
Prospective 
cohort study 
Maggiore Hospital in 
Bologna, Italy English 2010 
Pts > 14 yo with RLQ 
abdominal pain not 
needing immediate surgery 
159 NOM Oral abx (5 to 7 day course of amoxicillin + clavulanate 1g TID) N/A 
Treatment efficacy 
(short-term) 
El Khader 
2015 
Prospective 
cohort study 
Hôpital Militaire 
Avicenne in Marrakech, 
Morocco 
French 
September 
2010 - 
December 
2012 
Pts age 16-59 yo with 
uncomplicated acute 
appendicitis 
68 NOM 
IV abx (amoxicillin + clavulanate) 3g qd 
divided into 3 doses for 48 hrs + oral abx 
for 8 days 
N/A Treatment efficacy 
Hansson 
2012. 
Nonrandomized 
controlled trial 
Sahlgrenska University 
Hospital in Goteborg, 
Sweden 
English 
May 2009 - 
February 
2010 
Pts >16 yo with 
uncomplicated acute 
appendicitis 
558 total  
(442 NOM) 
IV abx (piperacillin + tazobactam 4g 
q8h) for at least 3 doses usually within 
24hrs + oral abx (ciprofloxacin 500mg + 
metronidazole 400mg BID) for 9 days 
Appendectomy Treatment efficacy and complications 
Kirkil 
2014 
Prospective 
cohort study Elazig, Turkey English 2010-2012 
Pts >18 yo w 
uncomplicated acute 
appendicitis 
118 NOM 
IV abx (ceftriaxone 1g BID and 500mg 
TID) + oral abx (ampicillin/sulbactam 
750mg BID + metronidazole 500mg 
TID) for 10 days 
N/A Treatment efficacy 
Lundholm 
2017 
Prospective 
cohort study Sweden English Unknown 
Pts >18 yo w 
uncomplicated acute 
appendicitis 
832 NOM 
(RCT = 119, 
PBT = 442, 
Non-R = 271) 
Abx treatment (no standard therapy 
regimen) Appendectomy Long-term harms 
Park 2011 Prospective cohort study Korea English 2007-2009 
Pts (no age specified) w 
uncomplicated acute 
appendicitis 
107 NOM 
IV abx (2nd-generation cephalosporin + 
metronidazole), oral feeding, and 
analgesics for 48hrs 
N/A Treatment efficacy 
Park 2014 Prospective cohort study Korea English 2010-2011 
Pts >18 you w RLQ and 
acute appendicitis 
diagnosed by CT or US 
with appendiceal diameter 
d10 mm 
119 NOM 
IV abx (2nd-generation cephalosporin + 
metronidazole) for 48hrs and fasting for 
24hrs + oral abx for 2 days 
N/A Treatment efficacy 
Salminen 
2015 
Prospective 
randomized 
controlled, 
open-label, 
non-inferiority 
multicenter trial 
6 Finnish hospitals: 3 
University (Turku, 
Tmpere, and Oulu) and 
3 Central (Mikkeli, 
Jyvaskla, and Seinajoki) 
English 
November 
2009 - June 
2012 
Pts age 18-60 yo admitted 
to the ED with CT 
confirmed uncomplicated 
acute appendicitis 
530 total  
(257 NOM) 
IV abx (ertapenem sodium 1g/d) for 3 
days followed by oral abx (levofloxacin 
500mg + metronidazole 500mg TID) for 
7 days 
Open 
appendectomy 
Treatment efficacy, 
post-intervention 
complications, 
recurrence of AA, 
LOS, treatment costs, 
sick leave 
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Table 3. Risk of Bias Analysis for Observational Studies 
First 
Author 
and Year 
Representativeness 
of exposed cohort 
Selection of non-
exposed cohort 
Ascertainment 
of exposure 
Demonstration outcome 
of interest was not 
present at start of study 
Comparability of 
cohorts on basis of 
design or analysis 
Assessment of 
outcome 
Follow-up long 
enough for 
outcomes to occur 
Adequacy of 
follow-up of 
cohorts 
Total category 
scores 
Alnaser 
2018 
Somewhat 
representative, only 
one site 
N/A, single cohort Hospital record, standardized 
N/A, outcome is 
treatment failure N/A, single cohort 
Judged clinically, 
no time point 
stated 
No, only 6 months 
Those lost to 
follow-up excluded 
from study 
Selection: 3/4 
Comparability: N/A 
Outcome: 0/3 
Bashir 
2015 
Selected group of 
patients, only those 
on ER shift of author 
Drawn from the 
same community as 
the exposed cohort 
Hospital record, 
not standardized 
N/A, outcome is 
treatment failure Yes 
Judged clinically, 
no time point 
stated 
Yes, follow-up for 1 
year No statement 
Selection: 2/4 
Comparability: 2/2 
Outcome: 1/3 
Di Saverio 
2014 
Somewhat 
representative, only 
one site 
N/A, single cohort Hospital record, standardized 
N/A, outcome is 
treatment failure N/A, single cohort 
Telephone call 
and patient 
questionnaire at 
7 days 
Yes, follow-up for 2 
years 
0 patients lost to 
follow-up 
Selection: 4/4 
Comparability: N/A 
Outcome: 3/3 
El Khader 
2015 
Somewhat 
representative, only 
one site 
N/A, single cohort Hospital record, standardized 
N/A, outcome is 
treatment failure N/A, single cohort 
Judged clinically 
at 48 hrs 
Yes, follow-up for 1 
year 
0 patients lost to 
follow-up 
Selection: 4/4 
Comparability: N/A 
Outcome: 3/3 
Hansson 
2012 
Somewhat 
representative, only 
one site 
Drawn from the 
same community as 
the exposed cohort 
Hospital record, 
standardized 
N/A, outcome is 
treatment failure 
Yes, Table 1 is 
comparable between 
the two cohorts 
Judged clinically 
within 12-24 hrs 
Yes, follow-up for 1 
year No statement 
Selection: 3/4 
Comparability: 2/2 
Outcome: 2/3 
Kirkil 2014 
Somewhat 
representative, only 
one site 
N/A, single cohort Hospital record, standardized 
N/A, outcome is 
treatment failure N/A, single cohort 
Judged clinically 
at 48 hrs 
Yes, median follow-
up for 23 months 
No statement, 
calculated 44 
patients lost to 
follow-up 
Selection: 4/4 
Comparability: N/A 
Outcome: 2/3 
Lundholm 
2017 
Somewhat 
representative, 
included RCT, 
population-based 
trial, and Non-RCT 
One of three groups 
taken from within 
RCT but controls 
not included 
Hospital record, 
not standardized 
between three 
groups 
Yes, long-term harms not 
present at baseline 
N/A, grouped into 
single cohort 
Hospital record 
and patient letter 
to determine 
harms 
Yes, maximum 
follow-up of 8 years No statement 
Selection: 3/4 
Comparability: N/A 
Outcome: 3/3 
Park 2011 
Somewhat 
representative, only 
one site 
N/A, single cohort Hospital record, standardized 
N/A, outcome is 
treatment failure N/A, single cohort 
Judged clinically 
at 48 hrs 
Yes, median follow-
up for 18 months No statement 
Selection: 4/4 
Comparability: N/A 
Outcome: 3/3 
Park 2014 
Somewhat 
representative, only 
one site, only patients 
with appendiceal 
diameter d10 mm 
N/A, single cohort Hospital record, standardized 
N/A, outcome is 
treatment failure N/A, single cohort 
Judged clinically, 
no time point 
stated 
Yes, median follow-
up for 14 months No statement 
Selection: 3/4 
Comparability: N/A 
Outcome: 2/3 
 
Table 4. Risk of Bias Analysis for Randomized Controlled Trials 
First Author 
and Year 
Random sequence 
generation 
Allocation 
concealment 
Blinding of participants 
and personnel 
Blinding of outcome 
assessment 
Incomplete outcome assessment Selective reporting Other bias 
Salminen 2015 
Insufficient information Sequential opaque envelopes 
No, but most of the 
treating surgeons were not 
part of the study team 
No, outcome judged 
clinically within 12-24 
hrs by surgeon on call 
242/257 (94.2%) received abx as 
randomized, 55 (22.7%) discontinued 
intervention, 30 (11.7%) lost to follow-up 
Protocol available and all 
outcomes reported No other sources 
Unclear risk Low risk Low risk High risk Low risk Low risk Low risk 
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Table 5. Study Outcomes and Results 
First 
Author 
and Year 
Primary Outcome Results Harms Secondary Outcome Results 
Initial NOM 
treatment 
failure rate 
Recurrence 
rate 
Overall 
NOM failure 
rate 
Alnaser 
2018 
Of 90 pts managed conservatively, treatment was 
successful in 68 (75.6%). 10 pts failed treatment during 
the initial admission (11.1%) and 12 pts had recurrence 
(13.3%). Of 22 pts that failed conservative management, 
12 had acute suppurative appendicitis, 3 had perforated, 
3 had appendicular abscess, 3 had appendicular mass.  
  11.1% 15.0% 24.4% 
Bashir 
2015 
Of 305 admitted with acute appendicitis, 176 were 
treated conservatively. Of those managed conservatively, 
150 (85.22%) were treated successfully.  
  9.1% 6.3% 14.8% 
Di Saverio 
2014 
Short-term (7 day) failure rate was 11.9% (19/159). 6-
month failure rate was 10.7% (17/159) with 10 being 
treated with NOM. 1-year failure rate was 12.6% 
(20/159) with 12 being treated with NOM. 2-year failure 
rate was 13.8% (22/159) with 14 patients treated with 
NOM. Overall, 42 patients went to the OR over these 2 
years (42/159 = 26.4%) 
Incidence of intra-abdominal abscess was 
1/19 (5.3%) and surgical site infection was 
6/19 (31.6%). 
Mean length of hospital stay of 
nonoperatively managed patients was 0.4 
days. Mean sick leave period 5.8 days. 
Mean number of outpatient follow-up 
appointments was 1.3. Cost analysis 
showed overall costs of NOM and 
antibiotics to be €316.20 per patient. 
11.9% 16.4% 26.4% 
El Khader 
2015 
Conservative treatment was effective in 82.35% of cases 
(56/68). 5/56 pts (8.9%) were readmitted and operated 
for recurrence.  
2/5 patients readmitted with appendicitis 
after NOM had complicated appendicitis 
(appendiceal abscess and generalized 
peritonitis) 
Hospital LOS average of 3.7 days. 17.6% 8.9% 25.0% 
Hansson 
2012 
77% of pts treated non-operatively recovered while 23% 
(100/442) had subsequent appendectomy due to failed 
NOM. 38 pts (11%) had recurrent appendicitis at 1yr 
follow-up. 
 
Major complications within the 1yr 
follow-up did not different significantly 
between patients with NOM and those 
who had primary surgery. 
22.6% 11.1% 31.2% 
Kirkil 
2014 
2 pts (1.2%) did not have symptomatic relief within 
48hrs of abx. 16/118 pts (13.6%) experienced pain 
symptoms indicative of ongoing AA complications 
during follow-up. 7/10 underwent NOM a second-time. 
 
Statistical significance only for the 
presence of appendicolith [P=0.001, Exp 
(B)=0.058, B=- 2.845]. The Exp (B) 
value 0.058 implied that the presence of 
appendicolith measurably decreased the 
risk of recurrent appendicitis.  
1.3% 10.2% --- 
Lundholm 
2017 
The cumulative probability for relapse of appendicitis 
demanding appendectomy was: 0.09, 0.12, 0.12 and 0.13 
at 1-, 2-, 3- and 5-year follow-up, with a probability of 
0.86 ± 0.013 without appendectomy after 8 years. 
  14.7% 13.1% 25.8% 
Park 2011 
Of 107 patients, 97 (91%) had short-term resolution of 
symptoms. Of 97 patients, 5 (5.2%) had recurrent 
symptoms. 2 again chose abx and 3 underwent 
laparoscopic appendectomy. 
  9.3% 5.2% 14.0% 
Park 2014 
Of 119 pts, 9 did not respond to NOM. 14 of remaining 
pts had recurrence of symptoms, 3 of which were treated 
with NOM a second time. 
There were no severe postoperative 
complications, only 1 case of wound 
infection.  
2 of the 9 treatment failures were 
diagnosed with peritonitis. 7.6% 12.7% 19.3% 
Salminen 
2015 
Of 257 pts in abx group, 15 underwent appendectomy 
during initial hospitalization. During 1-yr follow-up, 55 
pts originally treated with NOM had recurrence of 
symptoms and were treated with appendectomy. 
The surgical complication rate for the 57 
patients in the antibiotic group who 
eventually underwent appendectomy was 
7.0% (4/57), compared to 20.5% (45/220) 
in the surgical group. 
LOS was statistically significantly 
shorter in the surgical group as compared 
to the abx-treated group. 4 pts (1.5%) in 
the surgical group were found to have 
appendiceal tumors. 
5.8% 22.7% 27.3% 
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